bpc 157 fda approval status 2025 bpc-157 BPC-157 FDA Approval Status 2026: Clinical Trials BPC-157 Canada Research Guide 2026:

The practical research question is whether activating this pathway can reduce food intake and body weight without relying only on GLP-1 signaling

That actually goes against the Hippocratic oath, which is do no harm and if we dont know if were causing harm, thats an issue.

Currently, however, there is a severe lack of human clinical data to support these claims, and fewer than five human trials are indexed in major databases, most with small sample sizes or unclear methodologies

(iii) and [serve] primarily as a financing mechanism for states, resulting in increased federal expenditures. Despite the safeguards implemented in the post-2022 approvals of DSHP, CMS has renewed concerns about the same issues originally identified in 2017, the letter states